Literature DB >> 15778513

Are we really on the right TRAIL?

Erika Cretney, Adam P Uldrich, Stuart P Berzins, Andreas Strasser, Dale I Godfrey, Mark J Smyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778513     DOI: 10.1385/IR:31:2:161

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  25 in total

1.  The critical role of LIGHT, a TNF family member, in T cell development.

Authors:  J Wang; T Chun; J C Lo; Q Wu; Y Wang; A Foster; K Roca; M Chen; K Tamada; L Chen; C R Wang; Y X Fu
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

Review 2.  The thymus and negative selection.

Authors:  Jonathan Sprent; Hidehiro Kishimoto
Journal:  Immunol Rev       Date:  2002-07       Impact factor: 12.988

Review 3.  TRAIL, Bim, and thymic-negative selection.

Authors:  Shi-Jun Zheng; Youhai H Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

Authors:  B Hilliard; A Wilmen; C Seidel; T S Liu; R Göke; Y Chen
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

5.  The TNF receptor family member CD30 is not essential for negative selection.

Authors:  A L DeYoung; O Duramad; A Winoto
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Positional cloning of the APECED gene.

Authors:  K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

7.  T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages.

Authors:  C J Guidos; J S Danska; C G Fathman; I L Weissman
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

Review 8.  Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.

Authors:  K Tomonari; S Fairchild; O A Rosenwasser
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

9.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  Normal thymocyte negative selection in TRAIL-deficient mice.

Authors:  Erika Cretney; Adam P Uldrich; Stuart P Berzins; Andreas Strasser; Dale I Godfrey; Mark J Smyth
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  1 in total

1.  Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.

Authors:  Hodaya Prinz-Hadad; Tehila Mizrachi; Michal Irony-Tur-Sinai; Tatyana B Prigozhina; Alexandra Aronin; Talma Brenner; Michal Dranitzki-Elhalel
Journal:  J Neuroinflammation       Date:  2013-03-09       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.